Investors Purchase Large Volume of Call Options on UnitedHealth Group (NYSE:UNH)

UnitedHealth Group Incorporated (NYSE:UNH) saw unusually large options trading on Wednesday. Stock investors purchased 164,087 call options on the company. This represents an increase of 30% compared to the average daily volume of 125,857 call options.

UnitedHealth Group Stock Performance

Shares of UnitedHealth Group stock opened at $353.51 on Thursday. The company has a market capitalization of $320.88 billion, a PE ratio of 26.70, a P/E/G ratio of 1.53 and a beta of 0.40. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.79 and a current ratio of 0.80. The company has a 50-day simple moving average of $290.76 and a two-hundred day simple moving average of $317.09. UnitedHealth Group has a one year low of $234.60 and a one year high of $438.85.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, April 21st. The healthcare conglomerate reported $7.23 EPS for the quarter, topping analysts’ consensus estimates of $6.76 by $0.47. UnitedHealth Group had a net margin of 2.68% and a return on equity of 14.65%. The business had revenue of $111.65 billion during the quarter, compared to the consensus estimate of $109.84 billion. During the same period in the previous year, the company posted $7.20 earnings per share. The firm’s revenue was up 2.0% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. Research analysts expect that UnitedHealth Group will post 18.43 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 17th. Stockholders of record on Monday, March 9th were paid a dividend of $2.21 per share. The ex-dividend date was Monday, March 9th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.5%. UnitedHealth Group’s payout ratio is presently 67.02%.

Wall Street Analyst Weigh In

Several analysts have recently weighed in on the company. Weiss Ratings downgraded UnitedHealth Group from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Monday, March 2nd. Wells Fargo & Company lifted their target price on UnitedHealth Group from $370.00 to $397.00 and gave the stock an “overweight” rating in a research report on Wednesday. Argus upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $400.00 target price for the company in a research report on Wednesday. UBS Group decreased their target price on UnitedHealth Group from $430.00 to $410.00 and set a “buy” rating for the company in a research report on Wednesday, January 28th. Finally, Jefferies Financial Group lifted their target price on UnitedHealth Group from $340.00 to $373.00 and gave the stock a “buy” rating in a research report on Monday. One research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, seven have assigned a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat, UnitedHealth Group has a consensus rating of “Moderate Buy” and a consensus target price of $377.68.

Institutional Investors Weigh In On UnitedHealth Group

Large investors have recently modified their holdings of the business. Sarver Vrooman Wealth Advisors purchased a new stake in shares of UnitedHealth Group during the fourth quarter worth about $25,000. Beacon Financial Strategies CORP acquired a new stake in shares of UnitedHealth Group during the fourth quarter worth about $26,000. Anfield Capital Management LLC lifted its holdings in shares of UnitedHealth Group by 220.0% during the fourth quarter. Anfield Capital Management LLC now owns 80 shares of the healthcare conglomerate’s stock worth $26,000 after purchasing an additional 55 shares during the period. Joseph Group Capital Management acquired a new stake in shares of UnitedHealth Group during the fourth quarter worth about $27,000. Finally, Nalls Sherbakoff Group LLC acquired a new stake in shares of UnitedHealth Group during the fourth quarter worth about $27,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Key Stories Impacting UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Q1 beat and raised guidance — UNH reported Q1 adjusted EPS of $7.23 (vs. consensus ~$6.76) and revenue of ~$111.7B, and raised FY‑2026 adjusted EPS guidance to above $18.25, citing improved management of medical costs. This is the main catalyst for the rally. Business Wire — Q1 Results
• Positive Sentiment: Analyst upgrades and price‑target increases — Multiple firms (Argus, RBC, Oppenheimer, Wells Fargo, Morgan Stanley, Jefferies, etc.) raised ratings or targets after the report, adding upward pressure as sell‑side momentum attracts buyers. 247wallst — Analyst Upgrades
• Positive Sentiment: AI & operational initiatives — Management flagged a meaningful AI investment (and Optum Real transaction scale), which investors view as a durable margin/efficiency tailwind if deployment scales as planned. That narrative supports higher multiple assumptions. Yahoo Finance — Q1 Deep Dive (AI)
• Positive Sentiment: Bullish options flow — Unusual activity: ~164k call options traded (≈30% above average), signaling short‑term bullish positioning from traders and institutional players.
• Neutral Sentiment: Sector sentiment spillover — UNH’s beat dragged peers higher (CVS, Humana, Centene); positive industry momentum can amplify the stock move but doesn’t change UNH’s fundamentals. Yahoo — Sector Impact
• Negative Sentiment: Ongoing risks remain — Management warned of challenges around a Medicare obesity‑drug pilot and cautioned that medical‑cost dynamics are still the key risk; if costs reaccelerate, margins and guidance could reverse. Reuters — Medicare Obesity Drug Pilot Challenges

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.